These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24624497)

  • 1. [Research and development of radiopharmaceuticals for PET scan].
    Nishimura S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Jan; 70(1):76-8. PubMed ID: 24624497
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory control in drug design of radiopharmaceuticals in Japan.
    Senda M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Jan; 70(1):73-5. PubMed ID: 24624496
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular tracers for the PET and SPECT imaging of disease.
    Pimlott SL; Sutherland A
    Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High efficiency synthesis of F-18 fluoromethyl ethers: an attractive alternative for C-11 methyl groups in positron emission tomography radiopharmaceuticals.
    Park C; Lee BS; Chi DY
    Org Lett; 2013 Sep; 15(17):4346-9. PubMed ID: 23930998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small animal PET in preclinical studies: opportunities and challenges.
    Riemann B; Schäfers KP; Schober O; Schäfers M
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):215-21. PubMed ID: 18551093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography (PET) and microfluidic devices: a breakthrough on the microscale?
    Audrain H
    Angew Chem Int Ed Engl; 2007; 46(11):1772-5. PubMed ID: 17285667
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter from the editors: positron emission tomography radiopharmaceuticals-current status.
    Freeman LM; Blaufox MD
    Semin Nucl Med; 2011 Jul; 41(4):243. PubMed ID: 21624558
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-standard radionuclide production for PET in Japan.
    Fujibayashi Y; Suzuki K; Fukumura T; Mori T; Kasamatsu S
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):140-4. PubMed ID: 18043540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and preliminary biological evaluations of [18F]-1-deoxy-1-fluoro-scyllo-inositol.
    Vasdev N; Chio J; van Oosten EM; Nitz M; McLaurin J; Vines DC; Houle S; Reilly RM; Wilson AA
    Chem Commun (Camb); 2009 Oct; (37):5527-9. PubMed ID: 19753345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation and radiolabelling by 18F-fluoroarylation of a dopamine D3-selective ligand as prospective imaging probe for PET.
    Höfling SB; Maschauer S; Hübner H; Gmeiner P; Wester HJ; Prante O; Heinrich MR
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6933-7. PubMed ID: 21030255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain.
    Yanamoto K; Kumata K; Yamasaki T; Odawara C; Kawamura K; Yui J; Hatori A; Suzuki K; Zhang MR
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1707-10. PubMed ID: 19217778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluorine-18 in radiopharmacy].
    de Beco V; Le Bars D; Scherrmann JM
    Ann Pharm Fr; 2008 Jan; 66(1):60-5. PubMed ID: 18435989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of iodine-124 and its applications in nuclear medicine.
    Braghirolli AM; Waissmann W; da Silva JB; dos Santos GR
    Appl Radiat Isot; 2014 Aug; 90():138-48. PubMed ID: 24747530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [11C]-dimethylamine as a labeling agent for PET biomarkers.
    Jacobson O; Mishani E
    Appl Radiat Isot; 2008 Feb; 66(2):188-93. PubMed ID: 17923410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and use of non-FDG PET radiopharmaceuticals at the Masaryk Memorial Cancer Institute.
    Adam J; Bolcak K; Kaderavek J; Kuzel F
    Klin Onkol; 2012; 25 Suppl 2():2S82-6. PubMed ID: 23581022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioimaging of positron-emitting 15O-labeled 2-deoxy-D-glucose of two-minute half-life.
    Yorimitsu H; Murakami Y; Takamatsu H; Nishimura S; Nakamura E
    Chem Asian J; 2007 Jan; 2(1):57-65. PubMed ID: 17441139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of endothelin-A receptor (radio)ligands for positron emission tomography.
    Michel K; Büther K; Law MP; Wagner S; Schober O; Hermann S; Schäfers M; Riemann B; Höltke C; Kopka K
    J Med Chem; 2011 Feb; 54(4):939-48. PubMed ID: 21275367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of (18)F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET.
    Robins EG; Zhao Y; Khan I; Wilson A; Luthra SK; Rstad E
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1749-51. PubMed ID: 20138515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New radiopharmaceuticals and positron-emission tomography applications at the Masaryk Memorial Cancer Institute in Brno].
    Adam J; Andres P; Bolcák K; Cermáková M; Demlová R; Dubská L; Sedlácková S; Valík D
    Klin Onkol; 2009; 22(3):94-7. PubMed ID: 19708542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
    Zimmer LA; Branstetter BF; Nayak JV; Johnson JT
    Laryngoscope; 2005 Nov; 115(11):2029-34. PubMed ID: 16319618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.